CEACAM5 and neoplasm: Using an anti-carcinoembryonic antigen (CEA) antibody conjugated with a BM104 fluorophore (SGM-101), Gutowski et al. were able to clearly delineate a CEA-expressing tumor with a tumor-to-background ratio of 3.5 [8].